COVID-19 aid would cause more problems than it would solve. SCOTUS opens the door to ending qualified immunity.

View in browser ([link removed] )

November 19, 2020

Technology-Covid-19-600 ([link removed] )

The Intersection of COVID Vaccines and Government Funding ([link removed] )

Moderna's vaccine cost the U.S. taxpayer $1 billion, while Pfizer’s cost nothing. Instead, Pfizer invested its own money in its research, and when asked about that, Pfizer’s CEO Dr. Bourla explained he “wanted to liberate our scientists from any bureaucracy.”

- The COVID Vaccine Trials & the Role of Government in Public Health ([link removed] )

By Terence Kealey

covid-19-flag-money ([link removed] )

Coronavirus Aid Would Be a Mistake for Long-term Economics ([link removed] )

Recent good news on vaccines shows light at the end of the tunnel. It would be tragic to pull out of the health crisis only to fall into a financial crisis caused by rising government debt.

- More Coronavirus Aid Would Push America Deeper into Debt ([link removed] )

By Chris Edwards

MULTIMEDIA

SCOTUS Gives Hope for the Beginning of the End of Qualified Immunity ([link removed] )

schweikert-pod ([link removed] )

Qualified immunity, the court invented doctrine that protects public officials from civil liability even in cases of egregious conduct, took a small hit at the Supreme Court recently. Jay Schweikert explains what it might mean long term.

LISTEN NOW
([link removed] )

Sign Up For Other Cato Newsletters
([link removed] )

SUPPORT CATO
([link removed] )

Facebook ([link removed] )

LinkedIn ([link removed] )

Twitter ([link removed] )

Instagram ([link removed] )

YouTube ([link removed] )

Cato Institute, 1000 Massachusetts Ave, NW, Washington, DC 20001, (202) 842-0200

Manage preferences ([link removed] )